Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THDB0206 vs Humalog in Type 2 Diabetes on Insulin Glargine
CTR20212853Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of BioChaperone Lispro in type 2 diabetes mellitus (T2DM), sponsored by Tonghua Dongbao. Started Dec 2021; status: completed.
02
Drugs
BioChaperone Lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20212853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212853.